Your browser doesn't support javascript.
loading
Dual-therapy with αvß3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.
Esser, Alison K; Schmieder, Anne H; Ross, Michael H; Xiang, Jingyu; Su, Xinming; Cui, Grace; Zhang, Huiying; Yang, Xiaoxia; Allen, John S; Williams, Todd; Wickline, Samuel A; Pan, Dipanjan; Lanza, Gregory M; Weilbaecher, Katherine N.
Afiliação
  • Esser AK; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Schmieder AH; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Ross MH; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Xiang J; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Su X; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Cui G; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Zhang H; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Yang X; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Allen JS; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Williams T; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Wickline SA; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Pan D; Department of Bioengineering, University of Illinois at Urbana, Urbana, IL, USA.
  • Lanza GM; Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: greg.lanza@mac.com.
  • Weilbaecher KN; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: kweilbae@wustl.edu.
Nanomedicine ; 12(1): 201-11, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26515754
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Sistemas de Transporte de Aminoácidos Neutros / Integrina alfaVbeta3 / Difosfonatos / Imidazóis / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Sistemas de Transporte de Aminoácidos Neutros / Integrina alfaVbeta3 / Difosfonatos / Imidazóis / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos